Archive

Acute Pain Market: Latest Study by DelveInsight Reveals a Lucrative Investment Opportunity and Growth Prospect | Neumentum, CGeneTech, Algomedix, Kures, Mylan Specialty, Viatris, Scilex, Vivozon

Delveinsight Business Research LLP As per DelveInsight, the Acute Pain Market is anticipated to evolve immensely in the coming years owing to the rise in awareness and understanding of the

Read Full Article

Cancer Cachexia Pipeline Analysis Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals, Competitive Landscape | AEterna Zentaris, Pfizer, Incyte, Smartfish, Caelus, Helsinn

Delveinsight Business Research LLP As per DelveInsight’s assessment, globally, about 15+ key pharma and biotech companies are working on 15+ pipeline drugs in the Cancer Cachexia therapeutics landscape based on

Read Full Article

Progressive Pulmonary Fibrosis Market Forecasts by DelveInsight Signal Groundbreaking Growth by 2032 | Boehringer Ingelheim, Bristol-Myers Squibb, FibroGen, Roche. Pliant Therapeutics, Vicore Pharma

Delveinsight Business Research LLP The Progressive Pulmonary Fibrosis Market in the 7MM was USD 891 million in 2021 and it is expected to grow by 2032. As per DelveInsight, the

Read Full Article

Primary Ciliary Dyskinesia Market Gearing Up for Outstanding Expansion During the Forecast Period (2023-32) | Parion Sciences, Vertex Pharmaceuticals, ReCode Therapeutics, Aerocrine AB, CEISO

Delveinsight Business Research LLP As per DelveInsight, the Primary Ciliary Dyskinesia Market is anticipated to evolve immensely in the coming years owing to the rise in the number of cases

Read Full Article

Chronic Obstructive Pulmonary Disease Pipeline Analysis (2023) Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals, Competitive Landscape | Tetherex, Mereo, Synairgen, GSK

Delveinsight Business Research LLP As per DelveInsight’s assessment, globally, about 65+ key pharma and biotech companies are working on 70+

Read Full Article

Acromegaly Pipeline Analysis (2023) Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals, Competitive Landscape | Ionis, Crinetics, Camurus, Aquestive, Peptron, DexTech

Delveinsight Business Research LLP As per DelveInsight’s assessment, globally, about 15+ key pharma and biotech companies are working on 15+

Read Full Article

Hanley Investment Group Arranges Sale of AutoZone-Occupied Two-Tenant Pad Building at Target-Anchored Shopping Center in Northern Los Angeles County for $2.65 Million

LANCASTER, Calif. – Hanley Investment Group Real Estate Advisors, a nationally recognized real estate brokerage and advisory firm specializing in

Read Full Article

DelveInsight Evaluates a Robust Encephalopathy Clinical Trial as 70+ Influential Pharma Companies to Set Foot in the 7MM

DelveInsight’s, “Encephalopathy Pipeline Insight, 2023” report provides comprehensive insights about 70+ companies and 70+ pipeline drugs in the Encephalopathy pipeline

Read Full Article

DelveInsight Evaluates a Robust Postoperative Pain Clinical Trial as 45+ Influential Pharma Companies to Set Foot in the 7MM

DelveInsight’s, “Postoperative Pain Pipeline Insight, 2023,” report provides comprehensive insights about 45+ companies and 50+ pipeline drugs in the Postoperative

Read Full Article

DelveInsight Evaluates a Robust Epilepsy Clinical Trial as 75+ Influential Pharma Companies to Set Foot in the 7MM

DelveInsight’s, “Epilepsy Pipeline Insight, 2023” report provides comprehensive insights about 75+ companies and 90+ pipeline drugs in Epilepsy pipeline landscape.

Read Full Article

Categories